The Global Hemoconcentrators Market to Surpass USD 12 Billion Mark by 2027, Assesses DelveInsight

The global hemoconcentrators market is anticipated to surge owing to the increase in the prevalence and burden of cardiovascular diseases, the rising geriatric population, and rising technological developments, among others.

New York, USA, Jan. 03, 2023 (GLOBE NEWSWIRE) — The Global Hemoconcentrators Market to Surpass USD 12 Billion Mark by 2027, Assesses DelveInsight

The global hemoconcentrators market is anticipated to surge owing to the increase in the prevalence and burden of cardiovascular diseases, the rising geriatric population, and rising technological developments, among others.

DelveInsight’s Hemoconcentrators Market Insights report provides the current and forecast market analysis, individual leading hemoconcentrators companies’ market shares, challenges, Hemoconcentrators market drivers, barriers, and trends, and key hemoconcentrators companies in the market.

Key Takeaways from the Hemoconcentrators Market Report

  • As per DelveInsight analysis, the global hemoconcentrators market is expected to grow at a CAGR of 3.76% during the forecast period (2022–2027).
  • As per DelveInsight estimates, North America is anticipated to dominate the global hemoconcentrators market during the forecast period. 
  • Notable hemoconcentrators companies such as MEDIVATORS Inc., Terumo Cardiovascular Systems Corporation, Getinge AB, Minntech Corporation, LivaNova PLC, Nipro Asia, Medica S.p.A, Braile Biomédica, Andocor, TEMED, and several others are currently operating in the hemoconcentrators market.

To read more about the latest highlights related to the hemoconcentrators market, get a snapshot of the key highlights entailed in the Global Hemoconcentrators Market Report

Hemoconcentrators Overview

A hemoconcentrator, also known as a hemofilter or ultrafiltration device, is made up of a semipermeable membrane that allows electrolytes and water from the blood to be transferred. It is primarily used to remove unwanted fluid during cardio bypass surgery. Hemoconcentrators can communicate with the cardiopulmonary bypass circuit (CPB) in various ways. It is usually connected to an extracorporeal circuit to monitor hemodilution and help maintain hematocrit levels. The use of a hemoconcentrator reduces the need for additional homologous blood and blood products after surgery because these devices conserve albumin, platelets, and coagulation factors. Hemoconcentrators reduce potassium loss while also reducing edoema, organ dysfunction, and protein concentration.

Hemoconcentration mechanisms are widely used in cardiopulmonary surgery for monitoring and influencing hemodilution and are now widely used by many surgeons and perfusionists worldwide. The hemoconcentrators are user-friendly devices that can be easily controlled and help to reduce the complications associated with postoperative bleeding.

Hemoconcentrators Market Insights

North America is expected to account for the largest share of the global hemoconcentrators market among all regions. The growing number of surgeries, the demand for advanced technologies in cardiopulmonary bypass equipment, and other factors are driving regional growth.

Furthermore, the risk of developing a cardiopulmonary disease in the United States is rising dramatically due to changing lifestyles and an aging population. This suggests that chronic disease will affect most Americans in the coming decades. This situation has created an urgent need for Hemoconcentrators to prevent and treat chronic disease.

Moreover, Europe and the Asia-Pacific region have the most potential for future growth in the global hemoconcentrators market. This is due to the increasing burden of cardiovascular diseases in both European and Asian countries.

To know more about why North America is leading the market growth in the hemoconcentrators market, get a snapshot of the Hemoconcentrators Market Outlook 

Hemoconcentrators Market Dynamics

The hemoconcentrators market is experiencing increased product demand for a variety of reasons. Cardiovascular surgery is becoming more common, necessitating cardiopulmonary bypass (CPB), which provides a bloodless field for cardiac surgery. The development of cardiopulmonary bypass has enabled advancements in cardiac surgery.

Furthermore, companies are increasing their research and development to create more effective and simple products. Moreover, COVID-19 has increased the demand for hemoconcentrators. The advanced technology helps new patient populations, such as COVID-19 patients and others who require lung support. As a result, such initiatives from companies and regulatory authorities are expected to assist the hemoconcentrators market and patients in their treatment, thereby driving the hemoconcentrators market growth.

However, certain factors, such as the need for trained professionals and complications during surgery, pose a minor impediment to hemoconcentrators market growth.

Get a sneak peek at the hemoconcentrators market dynamics @ Hemoconcentrators Market Dynamics Analysis

Report Metrics Details
Coverage Global
Study Period 2019–2027
Base Year 2021
Hemoconcentrators Market CAGR 3.76%
Projected Hemoconcentrators Market Size by 2027 USD 12.64 Billion
Key Hemoconcentrators Companies MEDIVATORS Inc., Terumo Cardiovascular Systems Corporation, Getinge AB, Minntech Corporation, LivaNova PLC, Nipro Asia, Medica S.p.A, Braile Biomédica, Andocor, TEMED, among others

Hemoconcentrators Market Assessment

  • Hemoconcentrators Market Segmentation
    • Market Segmentation By Product Type: Pediatric Hemoconcentrators, Adult Hemoconcentrators
    • Market Segmentation By End User: Hospitals, Ambulatory Surgical Centres, Others
    • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the hemoconcentrators market are set to emerge as the trendsetter explore @ Hemoconcentrators Companies 

Table of Contents 

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Hemoconcentrators Market
7 Hemoconcentrators Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Hemoconcentrators Market Company and Product Profiles
10 Project Approach
11 About DelveInsight

Interested in knowing the hemoconcentrators market by 2027? Click to get a snapshot of the Hemoconcentrators Market Trends

Related Reports

Implantable Cardiac Monitors (ICM) Market

Implantable Cardiac Monitors (ICM) Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key implantable cardiac monitors (ICM) companies, including Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, among others.

Cardiac Biomarkers Testing Market

Cardiac Biomarkers Testing Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac biomarkers testing companies, including Beckman Coulter, Inc, Siemens Healthcare GmbH, Abbott, among others.

Angio Suites Market

Angio Suites Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key angio suites companies, including Siemens, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, among others.

Intracardiac Echocardiography Devices Market

Intracardiac Echocardiography Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key intracardiac echocardiography devices companies, including Medtronic, Infraredx, Inc., Stryker, among others.

Cardiac Arrhythmia Monitoring Devices Market

Cardiac Arrhythmia Monitoring Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac arrhythmia monitoring devices companies, including Abbott Laboratories, Boston Scientific Corporation, Avanos Medical, among others.

Cardiac Resynchronization (CRT) Therapy Market

Cardiac Resynchronization (CRT) Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac resynchronization (CRT) therapy companies, including Abbott, Medtronic, Boston Scientific Corporation, BIOTRONIK, among others.

Other Trending Reports

Congestive Heart Failure (CHF) Market | Pulmonary Arterial Hypertension Market | Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) Market | Barlow’s Syndrome Market | Ebstein’s Anomaly | Kounis Syndrome Market | Restrictive Cardiomyopathy Market | Rheumatic Heart Disease Market | Portal Hypertension Market | Unstable Angina Market | Dilated Cardiomyopathy Market | Cardiogenic Shock Market | Chronic Pulmonary Hypertension Market | Abdominal Aortic Aneurysm Market

Related Healthcare Blogs

Upcoming Cardiovascular Diseases Drugs

Key Companies in the Cardiology Segment

Heart Failure Market

Top Cardiac Devices in the Market

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

CONTACT: Contact Us Shruti Thakur  [email protected]  +1(919)321-6187  https://www.delveinsight.com/medical-devices

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.